Mark ELBAN

Person

  • King of Prussia, PA, US

Patents Grantslast 30 patents

  • Information Patent Grant

    Hydroxypyridoxazepines as NRF2 activators

    • Patent number 11,945,826
    • Issue date Apr 2, 2024
    • GlaxoSmithKline Intellectual Property Development Limited
    • Mark Elban
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Hydroxy formamide derivatives and their use

    • Patent number 10,450,288
    • Issue date Oct 22, 2019
    • GlaxoSmithKline Intellectual Property (No. 2) Limited
    • Sarah E. Dowdell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents